Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Original Article

Volume 6, Number 6, December 2014, pages 429-434


Treatment of Severe Poison Ivy: A Randomized, Controlled Trial of Long Versus Short Course Oral Prednisone

Figure

Figure 1.
Figure 1. Patients enrollment flowchart.

Tables

Table 1. Patients Demographics
 
Short courseLong courseTotal
Male7613
Female201636
Age mean40.8934.0937.88 (SD 17.45, range 15 - 86)
Enrollment
  April134
  May336
  June9514
  July437
  August729
  September369

 

Table 2. Clinical Outcomes
 
Short course/27Long course/22Total/49P valueMean difference
Questionnaire181533
Telephone9718
Noncompliance reported1230.581
Reported improvement of rash2221430.204
Mean time to improvement4.42 days (SD 4.13 days)2.93 days (SD 1.23 days)0.109-1.49 days
Mean time to resolution14.63 days (SD 8.87 days)11.7 days (SD 7.39 days)0.23-2.93 days
Rash return?/td>4370.91
  Return in same location?/td>426
Side effects3030.239
Use of other medication:155200.02

 

Table 3. Statistical Significance of Use of Extra Medications
 
Short course/27Long course/22Total/49P value95% confidence intervals
Use of other medication:155200.02
  Prednisone, Rx9211
  Depo Medrol, Rx101
  Triamcinolone, Rx101
  Calamine, OTC246
  Antihistamine, OTC224
  Hydrocortisone cream, OTC303
  Gold bond lotion, OTC101
  Other lotion, OTC202
Event rate22.70%55.60%
Absolute risk reduction32.90%0.139 - 0.385
Relative risk reduction59.20%0.331 - 0.611
Number needed to treat3.052.60 - 7.19
Relative risk0.410.18 - 0.95
Odds ratio0.240.067 - 0.824